TriSalus Life Sciences (TLSI) Amortization of Deferred Charges (2024 - 2026)
TriSalus Life Sciences (TLSI) reported Amortization of Deferred Charges of $296000.0 for Q1 2026, up 67.23% on a YoY basis from $177000.0 in Q1 2025, and up 970.59% quarter-over-quarter from -$34000.0 in Q4 2025.
TriSalus Life Sciences (TLSI) Amortization of Deferred Charges (2024 - 2026) Analysis & Trends
TriSalus Life Sciences has reported Amortization of Deferred Charges for 3 years, with the latest figure at $296000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortization of Deferred Charges rose 67.23% year-over-year to $296000.0; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (up 23.17% YoY), and the FY2025 full-year result was $766000.0, up 26.82% from the prior year.
- Amortization of Deferred Charges for Q1 2026 stood at $296000.0, up from -$34000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $766000.0 in Q2 2025, with the low at -$34000.0 in Q4 2025.
- Historically, Amortization of Deferred Charges has averaged $278125.0 across 3 years, with a median of $232000.0 in 2024.
- The largest YoY upside for Amortization of Deferred Charges was 223.21% in 2025 against a maximum downside of 114.98% in 2025.
- TriSalus Life Sciences' Amortization of Deferred Charges stood at $227000.0 in 2024, then plunged by 114.98% to -$34000.0 in 2025, then jumped by 970.59% to $296000.0 in 2026.
- The last three Amortization of Deferred Charges figures came in at $296000.0 (Q1 2026), -$34000.0 (Q4 2025), and $200000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | TriSalus Life Sciences | 192.50 Mn | 135.95 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 296,000.00 |
| Mar 31, 2026 | 296,000.00 |
| Dec 31, 2025 | -34,000.00 |
| Dec 31, 2025 | -34,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 766,000.00 |
| Jun 30, 2025 | 766,000.00 |
| Mar 31, 2025 | 177,000.00 |
| Mar 31, 2025 | 177,000.00 |
| Dec 31, 2024 | 227,000.00 |
| Dec 31, 2024 | 227,000.00 |
| Sep 30, 2024 | 356,000.00 |
| Sep 30, 2024 | 356,000.00 |
| Jun 30, 2024 | 237,000.00 |
| Jun 30, 2024 | 237,000.00 |